Amgen (AMGN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Amgen Inc. (NASDAQ:AMGN) ranks among the best low volatility stocks to buy according to analysts. While keeping its ...

Amgen Inc. (NASDAQ:AMGN) is one of the top low volatility healthcare stocks to buy now. On July 23, BofA analyst Tim Anderson ...

Amgen: Reducing My Price Target, Reiterate Buy After A Solid Q1 May 04, 2025 10:30 AM ET Amgen Inc. (AMGN) Stock AMGN 3 Comments Mike Zaccardi, CFA, CMT 7.91K Follower s Play (7min) ...

The Zacks Medical - Biomedical and Genetics industry, to which Amgen belongs, has lost 0.6% over this period. Now the key question is: Where could the stock be headed in the near term?

Amgen (NASDAQ: AMGN) is doing something unusual in 2025. Here's why this $150 billion pharmaceutical powerhouse deserves a closer look by investors of all stripes. Amgen delivered stellar first ...

Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.